ID   HNRPK_RAT               Reviewed;         463 AA.
AC   P61980; Q07244; Q15671; Q60577; Q922Y7; Q96J62;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2004, sequence version 1.
DT   29-MAY-2024, entry version 175.
DE   RecName: Full=Heterogeneous nuclear ribonucleoprotein K;
DE            Short=hnRNP K;
DE   AltName: Full=dC stretch-binding protein;
DE            Short=CSBP;
GN   Name=Hnrnpk; Synonyms=Hnrpk;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Donryu; TISSUE=Liver;
RX   PubMed=8127654; DOI=10.1093/nar/22.1.53;
RA   Ito K., Sato K., Endo H.;
RT   "Cloning and characterization of a single-stranded DNA binding protein that
RT   specifically recognizes deoxycytidine stretch.";
RL   Nucleic Acids Res. 22:53-58(1994).
RN   [2]
RP   PROTEIN SEQUENCE OF 149-163, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Lubec G., Chen W.-Q.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [3]
RP   INTERACTION WITH RBM42.
RX   PubMed=19170760; DOI=10.1111/j.1365-2443.2008.01256.x;
RA   Fukuda T., Naiki T., Saito M., Irie K.;
RT   "hnRNP K interacts with RNA binding motif protein 42 and functions in the
RT   maintenance of cellular ATP level during stress conditions.";
RL   Genes Cells 14:113-128(2009).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: One of the major pre-mRNA-binding proteins. Binds tenaciously
CC       to poly(C) sequences. Likely to play a role in the nuclear metabolism
CC       of hnRNAs, particularly for pre-mRNAs that contain cytidine-rich
CC       sequences. Can also bind poly(C) single-stranded DNA. Plays an
CC       important role in p53/TP53 response to DNA damage, acting at the level
CC       of both transcription activation and repression. When sumoylated, acts
CC       as a transcriptional coactivator of p53/TP53, playing a role in
CC       p21/CDKN1A and 14-3-3 sigma/SFN induction. As far as transcription
CC       repression is concerned, acts by interacting with long intergenic RNA
CC       p21 (lincRNA-p21), a non-coding RNA induced by p53/TP53. This
CC       interaction is necessary for the induction of apoptosis, but not cell
CC       cycle arrest (By similarity). As part of a ribonucleoprotein complex
CC       composed at least of ZNF827, HNRNPL and the circular RNA circZNF827
CC       that nucleates the complex on chromatin, may negatively regulate the
CC       transcription of genes involved in neuronal differentiation (By
CC       similarity). {ECO:0000250, ECO:0000250|UniProtKB:P61978}.
CC   -!- SUBUNIT: Identified in the spliceosome C complex (By similarity).
CC       Interacts with ANKRD28 and ZIK1 (By similarity). Interacts with DDX1
CC       (By similarity). Interacts with MDM2; this interaction leads to
CC       ubiquitination and proteasomal degradation (By similarity). Interacts
CC       with p53/TP53 (By similarity). Interacts with BRDT (By similarity).
CC       Interacts with RBM42 (PubMed:19170760). Interacts with IVNS1ABP (By
CC       similarity). Interacts with PPIA/CYPA (By similarity). Part of a
CC       transcription inhibitory ribonucleoprotein complex composed at least of
CC       the circular RNA circZNF827, ZNF827 and HNRNPL (By similarity).
CC       {ECO:0000250|UniProtKB:P61978, ECO:0000250|UniProtKB:P61979,
CC       ECO:0000269|PubMed:19170760}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P61978}.
CC       Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P61978}. Cell projection,
CC       podosome {ECO:0000250|UniProtKB:P61978}.
CC   -!- PTM: Sumoylated by CBX4. Sumoylation is increased upon DNA damage, such
CC       as that produced by doxorubicin, etoposide, UV light and camptothecin,
CC       due to enhanced CBX4 phosphorylation by HIPK2 under these conditions
CC       (By similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated by MDM2. Doxorubicin treatment does not affect
CC       monoubiquitination, but slightly decreases HNRNPK poly-ubiquitination
CC       (By similarity). {ECO:0000250}.
CC   -!- PTM: O-glycosylated (O-GlcNAcylated), in a cell cycle-dependent manner.
CC       {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D17711; BAA04566.1; -; mRNA.
DR   PIR; S41495; S41495.
DR   RefSeq; NP_476482.1; NM_057141.1.
DR   RefSeq; XP_006253616.1; XM_006253554.3.
DR   AlphaFoldDB; P61980; -.
DR   SMR; P61980; -.
DR   BioGRID; 250729; 7.
DR   IntAct; P61980; 84.
DR   MINT; P61980; -.
DR   STRING; 10116.ENSRNOP00000025980; -.
DR   GlyGen; P61980; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P61980; -.
DR   PhosphoSitePlus; P61980; -.
DR   SwissPalm; P61980; -.
DR   jPOST; P61980; -.
DR   PaxDb; 10116-ENSRNOP00000025980; -.
DR   GeneID; 117282; -.
DR   KEGG; rno:117282; -.
DR   UCSC; RGD:71058; rat.
DR   AGR; RGD:71058; -.
DR   CTD; 3190; -.
DR   RGD; 71058; Hnrnpk.
DR   VEuPathDB; HostDB:ENSRNOG00000019113; -.
DR   eggNOG; KOG2192; Eukaryota.
DR   InParanoid; P61980; -.
DR   OrthoDB; 465127at2759; -.
DR   Reactome; R-RNO-4570464; SUMOylation of RNA binding proteins.
DR   Reactome; R-RNO-72163; mRNA Splicing - Major Pathway.
DR   Reactome; R-RNO-72203; Processing of Capped Intron-Containing Pre-mRNA.
DR   PRO; PR:P61980; -.
DR   Proteomes; UP000002494; Chromosome 17.
DR   Bgee; ENSRNOG00000019113; Expressed in thymus and 19 other cell types or tissues.
DR   ExpressionAtlas; P61980; baseline and differential.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0043679; C:axon terminus; IDA:RGD.
DR   GO; GO:0071013; C:catalytic step 2 spliceosome; ISO:RGD.
DR   GO; GO:0005938; C:cell cortex; IDA:RGD.
DR   GO; GO:0000785; C:chromatin; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0010494; C:cytoplasmic stress granule; ISO:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005654; C:nucleoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0002102; C:podosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0032993; C:protein-DNA complex; IDA:RGD.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0042805; F:actinin binding; IPI:RGD.
DR   GO; GO:0051117; F:ATPase binding; IPI:RGD.
DR   GO; GO:1990829; F:C-rich single-stranded DNA binding; IDA:RGD.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:RGD.
DR   GO; GO:0031072; F:heat shock protein binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0005521; F:lamin binding; IPI:RGD.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:RGD.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:1990715; F:mRNA CDS binding; IDA:RGD.
DR   GO; GO:0030628; F:pre-mRNA 3'-splice site binding; IDA:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; IDA:RGD.
DR   GO; GO:0003723; F:RNA binding; ISO:RGD.
DR   GO; GO:0003697; F:single-stranded DNA binding; IDA:RGD.
DR   GO; GO:0006953; P:acute-phase response; IEP:RGD.
DR   GO; GO:0043010; P:camera-type eye development; IEP:RGD.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEP:RGD.
DR   GO; GO:1904322; P:cellular response to forskolin; IDA:RGD.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IDA:RGD.
DR   GO; GO:0071284; P:cellular response to lead ion; IEP:RGD.
DR   GO; GO:0072752; P:cellular response to rapamycin; IEP:RGD.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IDA:RGD.
DR   GO; GO:0021766; P:hippocampus development; IEP:RGD.
DR   GO; GO:0001822; P:kidney development; IEP:RGD.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0030324; P:lung development; IEP:RGD.
DR   GO; GO:0008584; P:male gonad development; IEP:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IDA:SynGO.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:RGD.
DR   GO; GO:2000173; P:negative regulation of branching morphogenesis of a nerve; IMP:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:RGD.
DR   GO; GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0001541; P:ovarian follicle development; IMP:RGD.
DR   GO; GO:0007422; P:peripheral nervous system development; IEP:RGD.
DR   GO; GO:1903861; P:positive regulation of dendrite extension; IMP:RGD.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IMP:RGD.
DR   GO; GO:1900273; P:positive regulation of long-term synaptic potentiation; IMP:RGD.
DR   GO; GO:0031643; P:positive regulation of myelination; IMP:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:RGD.
DR   GO; GO:2000010; P:positive regulation of protein localization to cell surface; IMP:RGD.
DR   GO; GO:0048260; P:positive regulation of receptor-mediated endocytosis; ISO:RGD.
DR   GO; GO:0033120; P:positive regulation of RNA splicing; IMP:RGD.
DR   GO; GO:0090129; P:positive regulation of synapse maturation; IMP:RGD.
DR   GO; GO:0050806; P:positive regulation of synaptic transmission; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:1902165; P:regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; ISO:RGD.
DR   GO; GO:0010988; P:regulation of low-density lipoprotein particle clearance; ISO:RGD.
DR   GO; GO:0048024; P:regulation of mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0099175; P:regulation of postsynapse organization; IDA:SynGO.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:1902074; P:response to salt; IEP:RGD.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   GO; GO:0048538; P:thymus development; IEP:RGD.
DR   CDD; cd22432; KH-I_HNRNPK_rpt1; 1.
DR   CDD; cd22433; KH-I_HNRNPK_rpt2; 1.
DR   CDD; cd22434; KH-I_HNRNPK_rpt3; 1.
DR   Gene3D; 3.30.1370.10; K Homology domain, type 1; 3.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   InterPro; IPR012987; ROK_N.
DR   PANTHER; PTHR10288:SF344; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; 1.
DR   PANTHER; PTHR10288; KH DOMAIN CONTAINING RNA BINDING PROTEIN; 1.
DR   Pfam; PF00013; KH_1; 3.
DR   Pfam; PF08067; ROKNT; 1.
DR   SMART; SM00322; KH; 3.
DR   SUPFAM; SSF54791; Eukaryotic type KH-domain (KH-domain type I); 3.
DR   PROSITE; PS50084; KH_TYPE_1; 3.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Cell junction; Cell projection; Cytoplasm;
KW   Direct protein sequencing; DNA-binding; Glycoprotein; Isopeptide bond;
KW   Methylation; mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Repressor; Ribonucleoprotein; RNA-binding;
KW   Spliceosome; Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..463
FT                   /note="Heterogeneous nuclear ribonucleoprotein K"
FT                   /id="PRO_0000050099"
FT   DOMAIN          42..104
FT                   /note="KH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   REPEAT          54..76
FT                   /note="1-1"
FT   REPEAT          59..62
FT                   /note="3-1"
FT   DOMAIN          144..209
FT                   /note="KH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   REPEAT          245..250
FT                   /note="2-1"
FT   REPEAT          257..260
FT                   /note="3-2"
FT   REPEAT          267..270
FT                   /note="3-3"
FT   REPEAT          295..298
FT                   /note="3-4"
FT   REPEAT          324..329
FT                   /note="2-2"
FT   DOMAIN          387..451
FT                   /note="KH 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   REPEAT          399..421
FT                   /note="1-2"
FT   REPEAT          404..407
FT                   /note="3-5"
FT   REGION          1..276
FT                   /note="Necessary for interaction with DDX1"
FT                   /evidence="ECO:0000250"
FT   REGION          1..37
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          54..421
FT                   /note="2 X 22 AA approximate repeats"
FT   REGION          59..407
FT                   /note="5 X 4 AA repeats of G-X-G-G"
FT   REGION          209..337
FT                   /note="Interaction with ZIK1"
FT                   /evidence="ECO:0000250"
FT   REGION          236..273
FT                   /note="RNA-binding RGG-box"
FT   REGION          245..329
FT                   /note="2 X 6 AA approximate repeats"
FT   REGION          250..329
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        19..37
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         34
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61979"
FT   MOD_RES         36
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         39
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P61979"
FT   MOD_RES         75
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         198
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P61979"
FT   MOD_RES         214
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         216
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         219
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61979"
FT   MOD_RES         284
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         316
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         377
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P61979"
FT   MOD_RES         379
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         380
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   MOD_RES         405
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61979"
FT   MOD_RES         420
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        34
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        34
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        52
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        60
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        163
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        163
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        219
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        405
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        422
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        422
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
FT   CROSSLNK        422
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P61978"
SQ   SEQUENCE   463 AA;  50976 MW;  0F70EE169B2A064A CRC64;
     METEQPEETF PNTETNGEFG KRPAEDMEEE QAFKRSRNTD EMVELRILLQ SKNAGAVIGK
     GGKNIKALRT DYNASVSVPD SSGPERILSI SADIETIGEI LKKIIPTLEE GLQLPSPTAT
     SQLPLESDAV ECLNYQHYKG SDFDCELRLL IHQSLAGGII GVKGAKIKEL RENTQTTIKL
     FQECCPHSTD RVVLIGGKPD RVVECIKIIL DLISESPIKG RAQPYDPNFY DETYDYGGFT
     MMFDDRRGRP VGFPMRGRGG FDRMPPGRGG RPMPPSRRDY DDMSPRRGPP PPPPGRGGRG
     GSRARNLPLP PPPPPRGGDL MAYDRRGRPG DRYDGMVGFS ADETWDSAID TWSPSEWQMA
     YEPQGGSGYD YSYAGGRGSY GDLGGPIITT QVTIPKDLAG SIIGKGGQRI KQIRHESGAS
     IKIDEPLEGS EDRIITITGT QDQIQNAQYL LQNSVKQYSG KFF
//
